Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Integrated AI Pulmonary Workflow System Streamlines Detection and Follow-Up

By HospiMedica International staff writers
Posted on 19 May 2026

Pulmonary conditions such as chronic obstructive pulmonary disease, lung nodules, and pulmonary embolism require rapid identification and coordinated follow-up across emergency, inpatient, and ambulatory settings. More...

Fragmented workflows and missed handoffs can delay treatment and undermine continuity of care, making it harder for hospitals to keep patients on guideline-directed pathways. These gaps may contribute to avoidable readmissions and missed significant findings. A new system has launched that unifies acute and chronic pulmonary workflows with embedded artificial intelligence (AI) and electronic health record integration to streamline detection, coordination, and follow-through.

Viz.ai (San Francisco, CA, USA) has introduced the Viz Pulmonary Suite, an integrated AI-powered solution within the Viz.ai enterprise platform designed to streamline care delivery for pulmonary conditions. The suite brings acute and chronic pulmonary workflows together in a single solution and is designed to help health systems improve patient retention and outcomes by supporting guideline-directed care. It integrates seamlessly with electronic health record systems and includes specialized tools for chronic obstructive pulmonary disease, lung nodules, and pulmonary embolism.

The technology combines context‑aware patient summaries and guideline surfacing with condition‑specific tools to reduce missed diagnoses and treatment delays. By consolidating identification, coordination, and follow‑through into one EHR‑integrated workflow, the suite is intended to help clinicians intervene earlier and manage patients more consistently across care venues. Early findings across participating healthcare partners are described as promising.

Within the suite, Viz PE was associated with reduced time to treatment from 1.75 days to 0.56 days and lower in‑hospital mortality among high‑risk pulmonary embolism patients in a single‑center study. The company also noted the prevalence of gaps in identification and follow‑up across chronic lung disease, reinforcing the need for connected workflows that support timely action on critical findings. Viz.ai plans to showcase and demo the Viz Pulmonary Suite at the American Thoracic Society Annual Conference (booth #1944) from May 17–19, 2026.

“Pulmonary care breaks down not because we lack treatments, but because patients may be lost between moments of care. Across COPD, pulmonary embolism, and lung nodules, critical findings are often identified but not acted on in time due to fragmented workflows. The Viz Pulmonary Suite brings identification, coordination, and follow-through into a single solution that is fully integrated with the EHR, helping clinicians intervene earlier and manage these patients with greater consistency.” said Tim Showalter, MD, Chief Medical Officer of Viz.ai.

“Solutions like the Viz Pulmonary Suite provide clinical teams with connected AI-enabled workflows to help identify potential patients earlier, act more efficiently, and support more consistent follow-up across the care continuum.” said Lakshman Swamy, MD, MBA, FCCP, Chief Pulmonologist at Monogram Health.

Related Links
Viz.ai


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.